Stefano M. Santini
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC).
Journal: Vaccines
Published: August 05, 2024
Machine Learning Reassessment of Serum Immune Factors Shows No Unique Immune Profiles Linked to Disease Outcomes in SARS-CoV-2-infected Patients at Hospital Admittance.
Journal: European journal of immunology
Published: July 24, 2024
Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
Journal: Cytokine & growth factor reviews
Published: September 24, 2020
Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma.
Journal: Cancer immunology, immunotherapy : CII
Published: January 16, 2020
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 28, 2019
Lenalidomide improves the therapeutic effect of an interferon-α-dendritic cell-based lymphoma vaccine.
Journal: Cancer immunology, immunotherapy : CII
Published: February 15, 2019
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy.
Journal: Oncoimmunology
Published: January 17, 2017
NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 16, 2016
IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Journal: Handbook of experimental pharmacology
Published: November 26, 2008
Showing 1-12 of 12
Last Updated: 09/26/2026